Drug induced liver injury: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{See Also|Hy's law}} | {{See Also|Hy's law}} | ||
'''For patient information, click [[Drug induced liver injury (patient information)|here]]'''<br><br> | '''For patient information, click [[Drug induced liver injury (patient information)|here]]'''<br><br> | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{Rachita}} <br> | ||
{{SK}} DILI; Drug-induced liver injury; Drug induced hepatitis; drug induced liver toxicity | {{SK}} DILI; Drug-induced liver injury; Drug induced hepatitis; drug induced liver toxicity | ||
Revision as of 16:17, 13 July 2016
|
Drug induced liver injury Microchapters |
|
Differentiating Drug Induced Liver Injury from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Drug Induced Liver Injury On the Web |
|
American Roentgen Ray Society Images of Drug induced liver injury |
|
Risk calculators and risk factors for Drug induced liver injury |
Template:See Also
Template:See Also
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Rachita Navara, M.D. [2]
Synonyms and keywords: DILI; Drug-induced liver injury; Drug induced hepatitis; drug induced liver toxicity
Overview
Historical Perspective
Pathophysiology
Classification
Causes
Differentiating Drug induced liver injury from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Liver Biopsy | Other Diagnostic Studies
Treatment
Medical Therapy | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies